103
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Insulin micropiles comprising biodegradable polymers for production of a long-term hypoglycemic effect

, , , &
Pages 212-218 | Received 17 Nov 2009, Accepted 22 Apr 2010, Published online: 14 Jun 2010

References

  • Amino Y, Kawada K, Toi K, Kumashiro I, Fukushima K. (1988). “Phenylalanine derivatives enhancing intestinal absorption of insulin in mice”. Chem Pharm Bull, 36, 4426–4434.
  • Birchall JC. (2007) Stratum corneum bypassed or removed, Chap 18. In: Touitou E and Barry BW, eds. “Enhancement in Drug Delivery” (pp. 337–351). New York: CRC Press.
  • Cunha AS, Grossiord JL, Puisieux F, Seiller M. (1997). “Insulin in W/O/W multiple emulsions: biological activity after oral administration in normal and diabetic rats”. J Microencapsul, 14,321–333.
  • Eaimtrakarn S, Prasad YVR, Ohno T, Konishi T, Yoshikawa Y, Shibata N, Takada K. (2002) “Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats”. J Drug Target, 10, 255–260.
  • Ge J, Wei Q, Patric PD. (2003). “Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acrtloyl-hydroxyethyl starch)-PLGA composite microspheres”. Pharm Res, 20, 452–459.
  • Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K. (2007a). “Sustained-release self-dissolving micropiles for percutaneous absorption of insulin in mice”. J Drug Target, 15, 323–356.
  • Ito Y, Murakami A, Maeda T, Sugioka N, Takada K. (2008a). “Evaluation of self-dissolving needles containing low molecular weight heparin (LMWH) in rats”. Int J Pharm, 349, 124–129.
  • Ito Y, Ohashi Y, Saeki A, Sugioka N, Takada K. (2008b). “Antihyperglycemic effect of insulin from self-dissolving micropiles in dogs”. Chem Pharm Bull, 56, 243–246.
  • Ito Y, Ohashi Y, Shiroyama K, Sugioka N, Takada K. (2008c). “Self-dissolving micropiles for the percutaneous absorption of human growth hormone in rats”. Biol Pharm Bull, 31, 1631–1633.
  • Ito Y, Saeki A, Shiroyama K, Sugioka N, Takada K. (2008d). “Percutaneous absorption of interferon-α by self-dissolving micropiles”. J Drug Target, 16, 243–249.
  • Ito Y, Shiroyama K, Yoshimitsu J, Ohashi Y, Sugioka N, Takada K. (2007b). “Pharmacokinetic and pharmacodynamic studies following percutaneous absorption of erythropoietin micropiles to rats”. J Control Rel, 121, 176–180.
  • Kofuji K, Murata Y, Kawashima S. (2005). “Sustained insulin release with biodegradation of chitosan gel beads prepared by cupper ions”. Int J Pharm, 303, 95–103.
  • Lina N, Niclas R, Patric G, Goran S. (2007). “Novel microneedle patches for active insulin delivery are efficient in maintaing glycaemic control: An initial comparison with subcutaneous administration”. Pharm Res, 24, 1381–388.
  • Matsuzawa A, Morishita M, Takayama K, Nagai T. (1995). “Absorption of insulin using water-in-oil-in-water emulsion from an enteral loop in rats”. Biol Pharm Bull, 18, 1718–1723.
  • Morishita I, Morishita M, Takayama K, Machida Y, Nagai T. (1992). “Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats”. Int J Pharm, 78, 9–16.
  • Morishita M, Matsuzawa A, Takayama K, Isowa K, Nagai T. (1998). “Improving insulin enteral absorption using water-in-oil-in-water emulsion”. Int J Pharm, 172, 189–198.
  • Morishita M, Morishita I, Takayama K, Machida Y, Nagai T. (1993). “Site dependent effect of aprotinin, sodium caprate Na2EDTA and sodium glycocholate on intestinal absorption of insulin”. Biol Pharm Bull, 16, 68–72.
  • Park JH, Allen MG, Prausnitz MR. (2006). “Polymer microneedles for controlled-release drug delivery”. Pharm Res, 23, 1008–1019.
  • Park JH, Ye M, Park K. (2005). Biodegradable polymers for microencapsulation of drugs. Molecules, 10, 146–161.
  • Sheshala R, Kok KP, Tusrida D, Bhavanasi KM, Thakur RRS. (2007). “Development and validation of HPLC-UV method for the determination of insulin in rat plasma: Application to pharmacokinetic study”. Chromatographia, 66, 805–809.
  • Suna C, Sung WK. (2003). “Controlled release of insulin from injectabele biodegradable triblock copolymer depot in ZDF rats”. Pharm Res, 12, 2008–2010.
  • Suzuki A, Morishita M, Kajita M, Takayama K, Isowa K, Chiba Y, Tokiwa S, Nagai T. (1998). “Enhanced colonic and rectal absorption of insulin using a multiple emulsion containing eicosapentaenoic acid and docosahexaenoic acid”. J Pharm Sci, 87, 1196–1202.
  • Takenaga M, Yamaguchi Y, Kitagawa A, Ogawa Y, Kawai S, Mizushima  Y, Igarashi R. (2004). “Optimum formulation for sustained-release insulin”. Int J Pharm, 271, 85–94.
  • Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y. (1996). “Enteral absorption of insulin in rats from mucoadhesive Chitosan coated liposomes”. Pharm Res, 13, 896–901.
  • Teply BA, Tong R, Jeong SY, Luther G, Sherifi I, Yim CH, Khademhosseini  A, Farokhzad OC, Langer RS, Cheng J. (2008). The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules. Biomaterials, 29, 1216–1223.
  • Tozaki H, Komoike J, Tada C, Maruyama T, Terabe A, Suzuki J. (1997). “Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon”. J Pharm Sci, 86, 1016–1021.
  • Utoguchi N, Watanabe Y, Shida T, Matsumoto M. (1998). “Nitric oxide donors enhance rectal absorption of macromolecules in rabbits”. Pharm Res, 15, 870–876.
  • Wermeling DP, Banks SL, Hudson DA, Gill HS, Gupta J, Prausnitz MR, Stinchcomb AL. (2008). “Micropiles permit transdermal delivery of a skin-impermeant medication to humans”. Proc Natl Acad Sci USA, 105, 2058–2063.
  • Wijaya M, Shawn PD, Nicholas RH, Jenny W, Harvinder SG, Mark RP. (2004). “Trandermal delivery of insulin using microneedles in vivo”. Pharm Res, 21, 947–952.
  • Xiong XY, Li YP, Li ZL, Zhou CL, Tam KC, Liu ZY, Xie GX. (2007). “Vesicles from pluonic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery”. J Cont Rel, 120, 11–17.
  • Yamamoto A, Taniguchi T, Rikyuu K, Tsuji T, Murakami M, Muranishi  S. (1994). “Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats”. Pharm Res, 11, 1496–1500.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.